{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:23:05Z","timestamp":1791490985930,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.vaccine.2022.01.026","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T15:19:59Z","timestamp":1642605599000},"page":"1082-1089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study"],"prefix":"10.1016","volume":"40","author":[{"given":"Lucy L.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"La","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan V.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Monach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Strymish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael R.","family":"Fillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Westyn","family":"Branch-Elliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.01.026_b0005","unstructured":"US Food and Drug Administration (FDA). COVID-19 Vaccines; 2021. https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines."},{"key":"10.1016\/j.vaccine.2022.01.026_b0010","doi-asserted-by":"crossref","unstructured":"Pradhan PM, Shen Z, Li C, Remucal MJ. Comparison of adverse events between COVID-19 and Flu vaccines. medRxiv 2021. 2021.09.22.21263711.","DOI":"10.1101\/2021.09.22.21263711"},{"issue":"5","key":"10.1016\/j.vaccine.2022.01.026_b0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.vaccine.2022.01.026_b0020","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.vaccine.2022.01.026_b0025","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.01.026_b0030","article-title":"Thrombosis after covid-19 vaccination","volume":"373","author":"Hunter","year":"2021","journal-title":"BMJ"},{"issue":"22","key":"10.1016\/j.vaccine.2022.01.026_b0035","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2022.01.026_b0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis With COVID-19 mRNA Vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.vaccine.2022.01.026_b0045","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after Covid-19 Vaccination in a Large Health Care Organization","volume":"385","author":"Witberg","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.01.026_b0050","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for Adverse Events After COVID-19 mRNA Vaccination","author":"Klein","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.vaccine.2022.01.026_b0055","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.01.026_b0060","doi-asserted-by":"crossref","unstructured":"Gazit S, Shlezinger R, Perez G, et al. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. medRxiv 2021. 2021.08.24.21262415.","DOI":"10.1101\/2021.08.24.21262415"},{"issue":"6","key":"10.1016\/j.vaccine.2022.01.026_b0065","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41591-021-01325-6","article-title":"Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2","volume":"27","author":"Ebinger","year":"2021","journal-title":"Nat Med"},{"issue":"32","key":"10.1016\/j.vaccine.2022.01.026_b0070","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2022.01.026_b0075","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2022.01.026_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109570","article-title":"Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals","volume":"36","author":"Lozano-Ojalvo","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2022.01.026_b0085","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijid.2021.05.034","article-title":"Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals","volume":"108","author":"Sasikala","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.01.026_b0090","series-title":"mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Stamatatos","year":"2021"},{"issue":"7867","key":"10.1016\/j.vaccine.2022.01.026_b0095","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.01.026_b0100","unstructured":"US Department of Veterans Affairs. COVID-19 Shared Data Resource. VINCI Infrastructure, editor; 2020."},{"issue":"7","key":"10.1016\/j.vaccine.2022.01.026_b0105","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/gerona\/glab071","article-title":"Updating and Validating the U.S. Veterans Affairs Frailty Index: Transitioning From ICD-9 to ICD-10","volume":"76","author":"Cheng","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.vaccine.2022.01.026_b0110","unstructured":"Canty A RB. Bootstrap R (S-Plus) Functions. R package version 1.3-28.; 2021."},{"key":"10.1016\/j.vaccine.2022.01.026_b0115","unstructured":"Davison AC HD. Bootstrap Methods and Their Applications. Cambridge University Press, Cambridge. ISBN 0-521-57391-2, http:\/\/statwww.epfl.ch\/davison\/BMA\/; 1997."},{"issue":"43","key":"10.1016\/j.vaccine.2022.01.026_b0120","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.15585\/mmwr.mm7043e2","article-title":"COVID-19 Vaccination and Non\u2013COVID-19 Mortality Risk\u2014Seven Integrated Health Care Organizations, United States, December 14, 2020\u2013July 31, 2021","volume":"70","author":"Xu","year":"2021","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.01.026_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.05.088","article-title":"Adverse events following mRNA SARS-CoV-2 vaccination among US nursing home residents","author":"Bardenheier","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.01.026_b0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PTS.0b013e318183a475","article-title":"Development and evaluation of the institute for healthcare improvement global trigger tool","volume":"4","author":"Classen","year":"2008","journal-title":"J Patient Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2022.01.026_b0135","first-page":"3","article-title":"Identifying adverse events after outpatient surgery: improving measurement of patient safety","volume":"25","author":"Rosen","year":"2016","journal-title":"BMJQual Saf"},{"issue":"1","key":"10.1016\/j.vaccine.2022.01.026_b0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PTS.0b013e31820d164b","article-title":"Applying trigger tools to detect adverse events associated with outpatient surgery","volume":"7","author":"Rosen","year":"2011","journal-title":"J Patient Saf"},{"issue":"1002","key":"10.1016\/j.vaccine.2022.01.026_b0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/pgmj.2008.075788","article-title":"The preliminary development and testing of a global trigger tool to detect error and patient harm in primary-care records","volume":"85","author":"de Wet","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.vaccine.2022.01.026_b0150","unstructured":"Institute for Healthcare Improvement. IHI Outpatient Adverse Event Trigger Tool. http:\/\/www.ihi.org\/resources\/Pages\/Tools\/OutpatientAdverseEventTriggerTool.aspx (accessed January 10 2022)."},{"key":"10.1016\/j.vaccine.2022.01.026_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-01609-4","article-title":"Is one vaccine dose enough if you've had COVID? What the science says","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.01.026_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103401","article-title":"SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors","volume":"68","author":"Frieman","year":"2021","journal-title":"EBioMedicine"},{"issue":"58","key":"10.1016\/j.vaccine.2022.01.026_b0165","doi-asserted-by":"crossref","first-page":"eabi6950","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals after mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2022.01.026_b0170","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149150","article-title":"First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19","volume":"131","author":"Mazzoni","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2022.01.026_b0175","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 Breakthrough Infections in Vaccinated Health Care Workers","author":"Bergwerk","year":"2021","journal-title":"N Engl J Med"},{"issue":"10279","key":"10.1016\/j.vaccine.2022.01.026_b0180","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(21)00501-8","article-title":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals","volume":"397","author":"Manisty","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2022.01.026_b0185","article-title":"Covid-19: Pfizer-BioNTech vaccine is \u201clikely\u201d responsible for deaths of some elderly patients, Norwegian review finds","volume":"373","author":"Torjesen","year":"2021","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.vaccine.2022.01.026_b0190","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","article-title":"A primer and comparative review of major US mortality databases","volume":"12","author":"Cowper","year":"2002","journal-title":"Ann Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:08:30Z","timestamp":1759403310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0264410X22000512"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}